Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2025
Title: Amy Aspelund: Innovator in Influenza Virus Research
Introduction
Amy Aspelund is a prominent inventor based in Fort Collins, Colorado. She has made significant contributions to the field of virology, particularly in the development of influenza virus technologies. Her innovative work has led to advancements in vaccine development and therapeutic applications.
Latest Patents
Amy Aspelund holds a patent for a recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB2. This invention provides a high growth influenza reassortant virus and viral vectors that exhibit significantly increased growth rates compared to unmodified influenza viruses. The patent also includes pharmaceutical compositions that utilize these reassortant viruses and their applications for vaccination purposes.
Career Highlights
Throughout her career, Amy has worked with notable companies such as Vivaldi Biosciences Inc. and Bluesky Immunotherapies GmbH. Her expertise in virology and vaccine development has positioned her as a key figure in the industry.
Collaborations
Amy has collaborated with esteemed colleagues, including Thomas Muster and Markus Wolschek. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Amy Aspelund's innovative work in influenza virus research exemplifies her dedication to advancing medical science. Her contributions have the potential to significantly impact vaccine development and public health.